I think the tie up with Promega, the move into Therapeutics, and the exosome space in general will see this company substantially re-rated this year.
Sure, a capital raise is likely.....and knowing David Williams he'd probably like to increase his exposure....but even with that occurring, the stock could easily reach a $200mln mkt cap this year.
If you're waiting for the cap raise, you may miss the ride.
I think the tie up with Promega, the move into Therapeutics, and...
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
66.0¢ |
Change
0.050(8.20%) |
Mkt cap ! $60.73M | |||
| Open | High | Low | Value | Volume |
| 61.0¢ | 66.0¢ | 61.0¢ | $296.4K | 471.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11184 | 66.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 67.0¢ | 23617 | 1 |
View Market Depth
| Last trade - 15.57pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
64.5¢ |
Change
0.050 ( 7.75 %) |
||||
| Open | High | Low | Volume | ||
| 63.5¢ | 64.5¢ | 62.0¢ | 31571 | ||
| Last updated 15.19pm 14/06/2024 ? | |||||
| IIQ (ASX) Chart |